Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Effects of BRD4 inhibition in AML
PubMed Similar studies Analyze with GEO2R
Differential gene expression in neuroblastoma cells after treatment with vehicle control, JQ1, panobinostat, or combination of JQ1 and panobinostat
Novel BET protein Proteolysis Targeting Chimera (BET-PROTAC) exerts superior lethal activity than Bromodomain Inhibitor (BETi) against post-myeloproliferative Neoplasm (MPN) Secondary (s) AML Cells
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Effects of Beta Catenin antagonist BC2059 in AML cells
PubMed Full text in PMC Similar studies Analyze with GEO2R
Synergistic activity of BET protein antagonist-based combinations in Mantle Cell Lymphoma cells sensitive or resistant to ibrutinib
DNA damage Signaling Pathway PCR Array to profile the expression of human genes regulating in the DNA damage response (DDR) network
iBET resistance
ChIP of BET proteins in iBET resistance [ChIP-seq]
PubMed Full text in PMC Similar studies SRA Run Selector
Genome wide expression analysis of BET inhibitor resistance [RNA-seq]
Genome wide expression analysis of BET inhibitor resistance
Gene expression profiles of MV-4-11 AML cells treated HDAC1/2 -selective inhibitor and Azacitidine
Gene expression profiling of MYC-amplified medulloblastoma cell lines treated by JQ1, a BET bromodomain inhibitor
BET bromodomain inhibitor JQ1 effect on MYC-amplified medulloblastoma cell lines
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Leukemic cell lines expression profile of OTX015 compared to JQ1 and DMSO controls
Gene expression analysis of B-ALL cells treated with BET inhibitor
Transcriptional changes induced by Brd4 inhibitor, AZD5153, in cancer cell lines
PubMed Similar studies Analyze with GEO2RSRA Run Selector
Transcriptional dependencies in diffuse intrinsic pontine glioma
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukemia
Differential gene expression analysis of pediatric acute myeloid leukemia cell lines treated with azacytidine and panobinostat alone or in combination and compared to vehicle treated cells.
BCL6 mediates Chemoresistance in Acute Myeloid Leukemia
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on